| |
|
|
|
|
|
ESA Biosciences, Inc. (a Magellan Biosciences Company) and RNA Medical have recently partnered in the distribution and sale of the LeadCare® II Analyzer, with RNA Medical focusing on the hospital point of care setting. The world’s only CLIA-waived blood-lead analyzer, LeadCare II improves clinical outcomes and is ideal for the physicians’ office, health clinic, Point of Care Testing or outreach-screening program.
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
Safe, fast, easy, and inexpensive to use, ESA developed LeadCare II with a grant from the U.S. Centers for Disease Control. No more waiting days for expensive lab analysis, or worrying about losing track of a child that needs follow-up care. LeadCare II delivers quantitative blood lead results equivalent to those reported by outside laboratories in just three minutes. It improves patient care by providing on-the-spot results, cuts your staffs' result-tracking and administrative time, and qualifies for reimbursement as a quantitative blood lead test (CPT code: 83655).
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
Lead analysis in your laboratory reduces turn-around time, cuts costs, and generates revenue while providing a needed service for your community. Using proven Anodic Stripping Voltammetry (ASV) and nearly 40 years of experience, ESA makes blood-lead analysis rapid and routine, without the high costs associated with other analytical methods. The Model 3010B system, incorporating unique instrumentation and pre-packaged reagents, consists of two components. The sensor unit includes a test electrode, a stirring assembly, and two electrodes that carry current and regulate potential. This process is
|
Company:
Date:
December 01, 2008
|
|
|
|
|